- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01177982
Reinforcement-Based Treatment for Pregnant Drug Abusers (HOME II)
January 10, 2017 updated by: National Institute on Drug Abuse (NIDA)
Objectives: This project is a Stage II behavioral development study designed to answer remaining critical questions necessary before disseminating Reinforcement Based Treatment (RBT) to the larger treatment community.
These questions focus on the levels of intensity of RBT most efficacious for substance-using pregnant patients.
Design: The proposed study utilizes a novel approach to conducting a controlled clinical trial, the sequential multiple assignment randomized trial (SMART) design.
Participants (N=220) will first be randomized at treatment outset into either treatment-as-usual RBT or a reduced intensity RBT.
All participants will receive a subsequent randomization based upon an assessment of their initial two weeks of treatment compliance.
Early-non-compliant participants will be randomized to receive either the same or an increased level of RBT treatment intensity while early-compliant participants will be randomized to receive either the same or decreased level of treatment intensity and scope.
Primary outcome measures include treatment completion, and maternal heroin, cocaine, and other illicit substance use.
Secondary outcome measures include maternal measures of HIV risk behavior, and psychosocial functioning and neonatal measures of length of hospitalization, and birth outcomes.
Significance: The proposed project's innovation includes: the novelty RBT, use of a cutting-edge SMART model, application of advanced statistical techniques and inclusion of a cost-effectiveness approach.
The proposed project's significance is exceedingly high, as it will lay the foundation for later Stage III studies focused on dissemination of stepped care treatment programs for drug-addicted pregnant women that can be implemented not only in comprehensive care clinics but in diverse community settings that provide services to such women.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
220
Phase
- Phase 2
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21224
- Johns Hopkins Bayview Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 46 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Treatment entry at or before 34 weeks EGA with singleton fetus.
- Evidence of opioid, cocaine and/or other primary illicit substance use.
Exclusion Criteria:
- Severe medical or psychiatric concomitant condition interfering with treatment or needing hospitalization.
- Age 17 years or younger.
- Geographical constraints. These women are admitted only for a residential detoxification and often have plans to obtain aftercare in an outpatient or residential facility in closer proximity to their home. Thus, this greater distance from CAP increases the likelihood that these women will not return to CAP and will not deliver in a hospital that functions under similar protocols that operate in Baltimore City for treating drug-exposed neonates.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Usual RBT (t-RBT)
Individual therapy CBT skills modules Functional assessment Behavior contracts Behavior graphing Tangible rewards MI feedback Recreation Outreach Social club Job club
|
Individual therapy CBT skills modules Functional assessment Behavior contracts Behavior graphing Tangible rewards MI feedback Recreation Outreach Social Club Job Club
|
|
Experimental: Reduced RBT (r-RBT)
Individual therapy Skills modules Functional assessment Behavior contracts Behavior graphing Tangible rewards MI feedback Recreation Outreach Social Club Job Club
|
Individual therapy CBT skills modules Functional assessment Behavior contracts Behavior graphing Tangible rewards MI feedback Recreation Outreach
|
|
Experimental: Abbreviated RBT (a-RBT)
Individual therapy CBT skills modules Functional assessment Behavior contracts Behavior graphing Recreation
|
Individual therapy CBT skills modules Functional assessment Behavior contracts Behavior graphing Recreation
a-RBT Individual therapy CBT skills modules Functional assessment Behavior contracts Behavior graphing Recreation r-RBT: Individual therapy Skills modules Functional assessment Behavior contracts Behavior graphing Tangible rewards MI feedback Recreation Outreach
|
|
Active Comparator: Enhanced RBT (e-RBT)
Individual therapy CBT skills modules Functional assessment Behavior contracts Behavior graphing Tangible rewards MI feedback Recreation Outreach Social club Job club Recovery housing CAP short term housing admission Recovery sponsor
|
Individual therapy CBT skills modules Functional assessment Behavior contracts Behavior graphing Tangible rewards MI feedback Recreation Outreach Social club Job Club Recovery housing CAP housing admission Recovery sponsor
t-RBT Individual therapy CBT skills modules Functional assessment Behavior contracts Behavior graphing Tangible rewards MI feedback Recreation Outreach Social club Job club e-RBT: Recovery housing CAP short term housing admission Recovery sponsor
|
|
Active Comparator: Early compliant t-RBT
r-RBT Individual therapy Skills modules Functional assessment Behavior contracts Behavior graphing Tangible rewards MI feedback Recreation Outreach t-RBT: Social club Job club
|
r-RBT Individual therapy Skills modules Functional assessment Behavior contracts Behavior graphing Tangible rewards MI feedback Recreation Outreach t-RBT: Social club Job club
|
|
Active Comparator: Early non-compliant t-RBT
t-RBT Individual therapy CBT skills modules Functional assessment Behavior contracts Behavior graphing Tangible rewards MI feedback Recreation Outreach Social club Job club e-RBT: Recovery housing CAP short term housing admission Recovery sponsor
|
a-RBT Individual therapy CBT skills modules Functional assessment Behavior contracts Behavior graphing Recreation r-RBT: Individual therapy Skills modules Functional assessment Behavior contracts Behavior graphing Tangible rewards MI feedback Recreation Outreach
t-RBT Individual therapy CBT skills modules Functional assessment Behavior contracts Behavior graphing Tangible rewards MI feedback Recreation Outreach Social club Job club e-RBT: Recovery housing CAP short term housing admission Recovery sponsor
|
|
Experimental: Early compliant r-RBT
a-RBT Individual therapy CBT skills modules Functional assessment Behavior contracts Behavior graphing Recreation r-RBT: Individual therapy Skills modules Functional assessment Behavior contracts Behavior graphing Tangible rewards MI feedback Recreation Outreach
|
Individual therapy CBT skills modules Functional assessment Behavior contracts Behavior graphing Recreation
a-RBT Individual therapy CBT skills modules Functional assessment Behavior contracts Behavior graphing Recreation r-RBT: Individual therapy Skills modules Functional assessment Behavior contracts Behavior graphing Tangible rewards MI feedback Recreation Outreach
|
|
Experimental: Early non-compliant r-RBT
r-RBT Individual therapy Skills modules Functional assessment Behavior contracts Behavior graphing Tangible rewards MI feedback Recreation Outreach t-RBT: Social Club Job Club
|
t-RBT Individual therapy CBT skills modules Functional assessment Behavior contracts Behavior graphing Tangible rewards MI feedback Recreation Outreach Social club Job club e-RBT: Recovery housing CAP short term housing admission Recovery sponsor
r-RBT Individual therapy Skills modules Functional assessment Behavior contracts Behavior graphing Tangible rewards MI feedback Recreation Outreach t-RBT: Social Club Job Club
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Treatment Completion
Time Frame: Delivery (data extracted from medical record)
|
Delivering a baby, regardless of delivery hospital, while enrolled in treatment.
|
Delivery (data extracted from medical record)
|
|
Substance use
Time Frame: Once monthly until delivery and at six weeks post-partum
|
Drug Use: Urinalysis testing and self reported use (days in past month) for opioids, cocaine and other illicit substance use.
|
Once monthly until delivery and at six weeks post-partum
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Alcohol
Time Frame: Once monthly until delivery and at six weeks post-partum
|
Alcohol use: Urinalysis testing and self-reported (days in past month) of alcohol use
|
Once monthly until delivery and at six weeks post-partum
|
|
Maternal Obstetrical Course/Outcome
Time Frame: Delivery (data extracted from medical record)
|
Available maternal data will be abstracted from the completed delivery record (i.e.., maternal urine toxicology results at delivery, complications during labor/delivery, placental abruption, type of delivery, maternal length of hospital stay).
|
Delivery (data extracted from medical record)
|
|
Birth outcomes
Time Frame: Delivery (data extracted from medical record)
|
Available birth outcome data will be extracted from infant medical records (i.e., birth weight, gestational age, infant complications).
|
Delivery (data extracted from medical record)
|
|
Length of Hospital Stay
Time Frame: Upon release of infant from hospital (data extracted from medical record)
|
Length of hospital stay is an indicator of health and well-being.
The total days in the Newborn Nursery, Pediatrics and Neonatal Intensive Care will be abstracted from the medical records.
|
Upon release of infant from hospital (data extracted from medical record)
|
|
APGAR scores
Time Frame: Delivery (data extracted from medical record)
|
Scores assigned at 1 and 5 minutes and any additional Apgar scoring if applicable will be extracted from the infant medical record
|
Delivery (data extracted from medical record)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Margaret Chisolm, MD, Johns Hopkins University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2009
Primary Completion (Actual)
January 1, 2014
Study Completion (Actual)
May 1, 2015
Study Registration Dates
First Submitted
August 6, 2010
First Submitted That Met QC Criteria
August 6, 2010
First Posted (Estimate)
August 9, 2010
Study Record Updates
Last Update Posted (Estimate)
January 11, 2017
Last Update Submitted That Met QC Criteria
January 10, 2017
Last Verified
July 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DA14979-06
- R01DA014979 (U.S. NIH Grant/Contract)
- DCNBR (NIDA)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Drug Use Disorders During Pregnancy
-
Stanford UniversityDavid Drover, MDCompletedDrug Metabolism During PregnancyUnited States
-
KU LeuvenUniversitaire Ziekenhuizen KU LeuvenCompletedMedication and Supplement Use During Pregnancy
-
University of Colorado, DenverNational Institute on Drug Abuse (NIDA)CompletedThe Influence of in Utero Cannabis Exposure on Neonatal Brain Morphology and Structural ConnectivityDrug Use | Neurodevelopmental Abnormality | Cannabis Use Disorder | PREG1 | Fetal Exposure During PregnancyUnited States
-
University of OklahomaUniversity of Washington; Casey Family Programs; University of Oklahoma Outreach and other collaboratorsRecruitingPregnancy Related | Substance Use Disorders | Alcohol Use Disorder (AUD) | Drug Use Disorders | Fetal Alcohol Spectrum Disorders | Fetal Alcohol Syndrome | Alcohol Use Complicating Pregnancy, First Trimester | Alcohol Use Complicating Pregnancy, Second Trimester | Alcohol Use Complicating Pregnancy,... and other conditionsUnited States
-
T. John Winhusen, PhDNational Institute on Drug Abuse (NIDA); Eunice Kennedy Shriver National Institute...CompletedPregnancy Related | Substance Use | Opioid Use Disorder | Drug Abuse | Drug Addiction | Drug Abuse in PregnancyUnited States
-
University of OklahomaChildren's Bureau - Administration for Children and Families; Oklahoma Department...RecruitingSubstance Use Disorders | Alcohol Use Disorder | Drug Use Disorders | Alcohol Use Complicating Pregnancy, Unspecified Trimester | Drug Use Complicating Pregnancy, Unspecified TrimesterUnited States
-
Albany Medical CollegeCompletedOpioid Use During Medical CareUnited States
-
Chestnut Health SystemsNational Institute on Drug Abuse (NIDA)Active, not recruitingPolysubstance Drug Use (Indiscriminate Drug Use)United States
-
Johns Hopkins Bloomberg School of Public HealthCompletedPregnancy | Alcohol Use | Drug Use | Sex | Sexual ActivityUnited States
-
Johns Hopkins Bloomberg School of Public HealthCompletedPregnancy | Contraception | Alcohol Use | Drug Use | Unprotected Sex | SexUnited States
Clinical Trials on Usual RBT (t-RBT)
-
Renibus Therapeutics, Inc.CompletedAKIUnited States, Australia, Canada
-
Renibus Therapeutics, Inc.CompletedChronic Kidney Disease | Healthy VolunteersUnited States
-
Renibus Therapeutics, Inc.CompletedChronic Kidney Disease | Healthy VolunteersUnited States
-
Renibus Therapeutics, Inc.CompletedChronic Kidney Disease | Healthy VolunteersUnited States
-
Renibus Therapeutics, Inc.Active, not recruitingPost-Operative Complications in Cardiac SurgeryUnited States, Canada
-
Renibus Therapeutics, Inc.CompletedPost-Operative Complications in Cardiac SurgeryUnited States, Canada
-
Johns Hopkins UniversityNational Institute on Drug Abuse (NIDA)Completed
-
University of MichiganCompletedGingival TissueUnited States
-
Renibus Therapeutics, Inc.Terminated
-
University of North Carolina, Chapel HillNational Institute on Drug Abuse (NIDA)Completed